Clonal Cytopenia of Undetermined Significance
📧 Sign up to get email alerts when something new happens for Clonal Cytopenia of Undetermined Significance.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Early Intervention in High Risk CCUS [EARLY_Phase 1]
This document announces an early-phase 1 clinical trial for individuals at high risk of clonal cytopenias, including clonal cytopenia of und…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
This ClinicalTrials.gov update describes the CHANCES study, which investigates clonal hematopoiesis and therapy-emergent myeloid neoplasms i…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia [Phase 2]
A Phase 2 clinical trial evaluating ascorbic acid with chemotherapy for relapsed/refractory lymphoma, clonal cytopenia of undetermined signi…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS) [Phase 2]
A Phase 2 clinical trial evaluating the use of statins in patients with clonal cytopenia of undetermined significance (CCUS) and myelodyspla…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: CHIP/CCUS Natural History Protocol
An NHLBI-supported protocol to study the natural history of clonal hematopoiesis of indeterminate potential and clonal cytopenia of undeterm…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms [Phase 2]
Phase 2 clinical trial evaluating curcumin to improve inflammation and symptoms in patients with clonal cytopenia of undetermined significan…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
This clinical trial update discusses a study of acquired pyruvate kinase deficiency in clonal myeloid neoplasms. The trial is currently acti…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: CHAPTER: Clonal Haematopoiesis Assessment: Prevention, Treatment and Research
A CHAPTER study named 'Clonal Haematopoiesis Assessment: Prevention, Treatment and Research' sponsored by CHOIR is currently recruiting to s…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia. [Phase 2]
Phase 2 study evaluating olutasidenib in IDH1-mutated clonal cytopenia of undetermined significance and lower-risk myelodysplastic syndromes…
-
CLINICAL_TRIALS other · 2026-02-23Clinical Trial Update: Pre-myeloid Cancer and Bone Marrow Failure Clinic Study [NA]
A Mayo Clinic clinical trial update for a study addressing pre-myeloid cancer and inherited bone marrow failure syndromes, currently recruit…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2A Decentralized Trial [Phase 2]
A Phase 2 decentralized clinical trial assessing enasidenib for patients with clonal cytopenia of undetermined significance (CCUS) and IDH2 …
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance [Phase 1]
A Phase 1 study evaluating Enasidenib in people with Clonal Cytopenia of Undetermined Significance (CCUS) has completed.
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study [Phase 2]
A Phase 2 clinical trial evaluating canakinumab to prevent progression to cancer in patients with clonal cytopenias of undetermined signific…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1 [Phase 2]
Phase 2 clinical trial update of ivosidenib for patients with clonal cytopenia of undetermined significance (CCUS) due to IDH1 mutations; th…